LeonaBio, Inc. (LONA) Executive Compensation
LeonaBio, Inc. (LONA) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: LONA
CIK: 1620463
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerMatthew Stover
Audit LocationSeattle, Washington, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-22 | 2026-09-18 | 8-K | 0001193125-26-397952 | View SEC Doc Filr Page |
| 3 | 2026-09-03 | 2026-08-24 | PRIMARY DOCUMENT | 0002126186-26-000001 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-08-31 | — | SCHEDULE 13D Filing | 0001655566-26-000003 | View SEC Doc Filr Page |
| 8-K | 2026-08-26 | 2026-08-26 | 8-K | 0001193125-26-368288 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-25 | — | SCHEDULE 13D/A Filing | 0001193125-26-365096 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-20 | — | SCHEDULE 13G/A Filing | 0001636587-26-000069 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001193125-26-352243 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-14 | 8-K | 0001193125-26-352208 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-04-09 | 4 | 0001193125-26-300876 | View SEC Doc Filr Page |
| 4 | 2026-07-09 | 2026-06-23 | 4 | 0001193125-26-299927 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-23 | 4 Filing | 0001843393-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-23 | 4 Filing | 0001580111-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-23 | 4 Filing | 0001790314-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-23 | 4 Filing | 0001679039-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-23 | 4 Filing | 0001722055-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-23 | 4 Filing | 0001164426-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-23 | 4 Filing | 0001225501-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-23 | 4 Filing | 0001763316-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-23 | 4 Filing | 0001258693-26-000011 | View SEC Doc Filr Page |
| 8-K | 2026-06-23 | 2026-06-22 | 8-K | 0001193125-26-279425 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0001104659-26-062870 | View SEC Doc Filr Page |
| ARS | 2026-05-11 | 2025-12-31 | ARS | 0001193125-26-217029 | View SEC Doc Filr Page |
| DEFA14A | 2026-05-11 | — | DEFA14A | 0001193125-26-217016 | View SEC Doc Filr Page |
| DEF 14A | 2026-05-11 | 2026-06-22 | DEF 14A | 0001193125-26-216742 | View SEC Doc Filr Page |
| 4 | 2026-05-07 | 2026-05-05 | 4 Filing | 0001580111-26-000007 | View SEC Doc Filr Page |